Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Noroviruses: Recent Updates

´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸÁö 2012³â 15±Ç 1È£ p.1 ~ 7
Á¤ÁÖ¿µ,
¼Ò¼Ó »ó¼¼Á¤º¸
Á¤ÁÖ¿µ ( Chung Ju-Young ) 
ÀÎÁ¦´ëÇб³ ÀÇ°ú´ëÇÐ »ó°è¹éº´¿ø ¼Ò¾Æû¼Ò³â°ú

Abstract


Noroviruses (NoVs) are one major etiologic agent in acute gastroenteritis (AGE) in all ages and are the primary cause of food-borne gastroenteritis worldwide. GII-4 NoVs has predominated since 1990s, and novel recombinant strains have been reported worldwide. Researchers face difficulties in making vaccines and therapeutic agents against NoVs due to the lack of cell culture and animal-model systems and the rapid emergence of novel variant strains. Recently, a randomized clinical trial for intranasal NoVs vaccine has been reported, which casts a light in the way of vaccine production. This review discusses the recent findings on the structure, immunity, and vaccination of NoVs.

Å°¿öµå

Norovirus; Gastroenteritis; Children; Vaccine

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

  

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS